riluzole has been researched along with Amyloid Deposits in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Mazumder, S | 1 |
McCann, H | 1 |
D'Silva, S | 1 |
Furlong, S | 1 |
Shepherd, CE | 1 |
Kril, JJ | 1 |
Halliday, GM | 1 |
Rowe, DB | 1 |
Kiernan, MC | 1 |
Tan, RH | 1 |
Okamoto, M | 1 |
Gray, JD | 1 |
Larson, CS | 1 |
Kazim, SF | 1 |
Soya, H | 1 |
McEwen, BS | 1 |
Pereira, AC | 1 |
2 other studies available for riluzole and Amyloid Deposits
Article | Year |
---|---|
Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Pl | 2023 |
Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Astrocytes; Cognition; Disease Models, Animal; Gene Expression; Hippocam | 2018 |